The Red Era: Living in Seclusion in a Siheyuan as a Boss

Chapter 626 Industry-Academic-Research Cooperation!!!
Driven by the "Traditional Chinese Medicine" revitalization strategy, the Chinese herbal medicine planting industry in Liujiazhuang has flourished, bringing tangible economic benefits to local villagers.

With the completion and operation of the Liujiazhuang modern Chinese herbal medicine trading market, it has become a regional Chinese herbal medicine distribution center.

Today, Liujiazhuang's Chinese herbal medicines not only occupy an important share in the domestic market, but are also exported overseas through a complete sales network.

From Japan and the Three Kingdoms of Korea in East Asia to Southeast Asian countries, and then to continental Europe and the Americas, Liujiazhuang's Chinese herbal medicine products have won the favor of customers from dozens of countries and regions around the world with their excellent quality and have established a good reputation in the international market.

In this bustling Chinese herbal medicine trading market, there is a bustling crowd and the aroma of medicine every day.

The annual transaction volume here has exceeded 10 billion yuan, making it an important distribution center for Chinese medicinal materials in the country.

The fact that the Chinese herbal medicine industry here has been able to develop to its current scale is closely related to the passion for traditional Chinese medicine passed down from generation to generation by the Liu family.

The people of Liujiazhuang not only engage in the cultivation of medicinal herbs, but also spare no effort to promote the development of traditional Chinese medicine, injecting vigorous vitality into the local economy.

From its humble beginnings as a college of traditional Chinese medicine founded in the mid-1960s, it has grown into the nationally renowned Yenching University of Chinese Medicine.

Although the school was established only more than 30 years ago, it has developed into a national key medical school with strong faculty and advanced teaching facilities.

Liujiazhuang College of Traditional Chinese Medicine was renamed Yenching University of Chinese Medicine in 1982; this year, it was successfully selected as a key construction university in the national "211 Project".

The school’s three disciplines of traditional Chinese medicine, integrated traditional Chinese and Western medicine, and traditional Chinese medicine have also been selected into the national “Double First-Class” construction discipline list.

It has become the chairman unit of the new Teaching Guidance Committee for Traditional Chinese Medicine and Integrated Traditional Chinese and Western Medicine majors in higher education institutions of the Ministry of Education.

Although "Yenching University of Chinese Medicine" was established relatively recently, in the past 30 years they have trained a large number of professionals in the field of traditional Chinese medicine and have made important contributions to the inheritance and development of the traditional Chinese medicine industry.

In its long-term educational practice, Yenching University of Chinese Medicine has been adhering to the school motto of "diligent in learning, benevolent and helpful".
Advocate the concept of "people's desire to learn, inheritance and innovation", adhere to the purpose of "establishing morality and educating people, educating people with culture", carry forward the spirit of "pursuing excellence and striving for perfection", highlight characteristics and strengthen advantages;
It is an education base for cultivating high-level innovative TCM talents in Xiaguo, a demonstration base for the reform of higher TCM education, a research base for TCM knowledge innovation and technological innovation, a medical base for preventing and treating major diseases and difficult illnesses, a humanistic base for promoting excellent traditional culture, and an international exchange base for promoting TCM to the world. It has made important contributions to the development of the health industry and the progress of civilization.

"Yenching University of Chinese Medicine" has become a famous institution of higher learning in traditional Chinese medicine that enjoys a high reputation both at home and abroad, integrating education, scientific research, medical care, and the dissemination of traditional Chinese medicine culture.

The Yenching University of Chinese Medicine (including its affiliated hospitals) currently has 4800 faculty and staff, including 1250 full-time teachers.

The college has 1 academician of the Chinese Academy of Engineering, 15 national medical masters, and a faculty team that combines old, middle-aged and young people, including famous experts and scholars from home and abroad and outstanding young and middle-aged teachers.

The college adheres to the fundamental task of cultivating morality and educating people, and focuses on drawing nourishment from the rich soil of Chinese culture and traditional Chinese medicine culture;
We will integrate the concept of "educating people with culture" into the entire work of educating people, and cultivate socialist builders and successors who are well-rounded in moral, intellectual, physical, aesthetic and labor aspects.

There are more than 2180 full-time students, including 965 graduate students (2604 doctoral students and 8864 master's students), 498 undergraduates, and international students.

The school is committed to building a talent training system with high-level education as the main focus for the future. It currently has more than a dozen undergraduate majors, including Traditional Chinese Medicine, Chinese Medicine, Chinese Medicine Manufacturing, Pharmacy, Acupuncture and Massage, Rehabilitation Therapy, Pharmacy Management, Nursing, Foreign Languages, Law, Bioengineering, Clinical Medicine of Traditional Chinese and Western Medicine, Big Data Management and Application, and Traditional Chinese Medicine Orthopedics.

"Yenching College of Chinese Medicine" is also one of the first institutions among the national colleges of traditional Chinese medicine to establish a doctoral degree program and a postdoctoral research mobile station.

The college has three postdoctoral research stations: Traditional Chinese Medicine, Chinese Pharmacology, and Integrated Traditional Chinese and Western Medicine.

It has 3 first-level disciplines that are authorized to confer doctoral degrees, and 35 second-level disciplines that are authorized to confer doctoral degrees;

5 first-level disciplines are authorized to confer master's degrees, covering 35 master's degree awarding points.

It has 4 professional degree categories, including 8 doctoral professional degree authorization points and 12 master's professional degree authorization points.

It became the secretariat of the Professional Degree Graduate Education Steering Committee of Traditional Chinese Medicine and Pharmacy of Xiaguo, and one of the units where the convener of the Discipline Evaluation Group of Traditional Chinese Medicine and Integrated Traditional Chinese and Western Medicine is located.

The college currently has 7 national first-class undergraduate professional construction sites, 1 basic discipline outstanding student training program 2.0 base, 1 national experimental teaching demonstration center, 1 national Chinese medicine clinical teaching and training demonstration center, 1 national talent training model innovation experimental zone, 10 national first-class undergraduate courses, 3 national teaching teams, 4 national ideological and political teaching teams, and 3 national off-campus practical education bases for college students.

学校获得国家级教学成果奖一等奖1项、二等奖5项，燕京市教学成果奖特等奖1项，一等奖10项、二等奖23项。

"Yenching University of Chinese Medicine" currently has more than 25 scientific research bases at the provincial and ministerial levels or above.

It includes the National International Science and Technology Cooperation Base, the Key Laboratory of the Ministry of Education, the Engineering Research Center of the Ministry of Education, the Discipline Innovation and Talent Attraction Base of Higher Education Institutions, the National Clinical Research Base of Traditional Chinese Medicine, the National Traditional Chinese Medicine Inheritance and Innovation Center, the Key Research Office of the State Administration of Traditional Chinese Medicine, the Third-level Laboratory of the State Administration of Traditional Chinese Medicine, the Key Laboratory of Yanjing City, and the Yanjing City International Science and Technology Cooperation Base.

The school currently has the College of Traditional Chinese Medicine, College of Chinese Medicine, College of Life Sciences, College of Acupuncture and Massage, Qihuang College, School of Management, School of Nursing, School of Humanities, School of National Studies, and International College.

There are school-level research institutions such as the Yenching Institute of Chinese Medicine, the Yenching National Institute of Chinese Medicine Constitution and Prevention of Diseases, the Yenching University of Chinese Medicine National Institute of Chinese Medicine Development and Strategy, and the Yenching University of Chinese Medicine National Institute of Chinese Medicine Higher Education.

In Liujiazhuang, which has a profound foundation in traditional Chinese medicine, it is precisely thanks to the abundant local talent pool that the local medicine industry has achieved leapfrog development.

Relying on its unique resources of traditional Chinese medicine and professional talents, "Yanjing Liujiazhuang Pharmaceutical Group" has risen rapidly and has now become a modern pharmaceutical company renowned both at home and abroad.

Not only does it have prescriptions for treating diseases that have been passed down from generation to generation by various Chinese medicine families, it also brings together a large number of compound talents who are proficient in traditional medicine and modern pharmaceutical technology, injecting a continuous source of innovative vitality into the development of the enterprise.

While "Liujiazhuang Pharmaceutical Group" is based in China, it is also actively expanding overseas.

Since the early 1980s, "Liujiazhuang Pharmaceutical Factory" has embarked on its overseas development journey.

After more than ten years of continuous efforts, the people of Liujiazhuang have now established wholly-owned joint ventures and stores in many countries and regions around the world, and the number of its overseas stores ranks first among its peers.

This achievement not only demonstrates the strong brand strength of "Liujiazhuang Pharmaceutical Group", but also highlights its firm determination and strategic vision for international development.

In the process of internationalization, Liujiazhuang Pharmaceutical is well aware of the importance of cultural integration.

Therefore, while opening branches in various places, "Liujiazhuang Pharmaceutical" also pays attention to integrating into local culture in order to narrow the distance with local consumers.

This cross-cultural integration strategy not only enhanced the brand image of "Liujiazhuang Pharmaceutical", but also won it wide recognition and praise in the international market.

The success of "Liujiazhuang Pharmaceutical" is inseparable from its profound brand foundation and unique cultural heritage.

On the road to international development, "Liujiazhuang Pharmaceutical" has always adhered to the corporate culture of "benevolence, righteousness, courtesy, wisdom and trustworthiness" and strict requirements for product quality.

This respect and inheritance of tradition has enabled "Liujiazhuang Pharmaceutical" to always maintain its unique brand charm and competitive advantage in the fierce market competition.

In recent years, with the strong support of national policies, more and more traditional Chinese medicine companies have emerged and achieved sustainable development results, with Liujiazhuang Pharmaceutical Group achieving the highest achievement.

According to national pharmaceutical industry statistics, the traditional Chinese medicine industry has grown steadily over the past year, with annual operating revenue reaching 11.3 billion yuan, a year-on-year increase of %.

Last year, the total profit of the national traditional Chinese medicine industry reached more than 32 billion yuan, a year-on-year increase of %.

The development of traditional Chinese medicine is ushering in a highlight moment, and its contribution to economic and social development has increased significantly. The pharmaceutical industry is a technology-intensive industry, and the research and development of new drugs and new technologies is the basis for ensuring the sustainable development of the industry.

After the Eighth Five-Year Plan, with the deepening of various reforms and the implementation of the strategy of "developing medicine through science and technology", great changes have taken place in the field of pharmaceutical research and production.

During this period, take "Liujiazhuang Pharmaceutical Group" as an example.

Over the past decade, the factory has developed a large number of new anti-infective, antipyretic and analgesic, diagnostic drugs and amino acid pharmaceutical products;

Including semi-synthetic penicillins, cephalosporins, quinolone antibiotics, etc. tend to be produced on a large scale;

The industrialization of important products such as natural vitamin E, roxithromycin, and azithromycin has been achieved;

The company has also made great progress in new dosage forms such as controlled-release, sustained-release, and transdermal;

A number of high-tech technologies such as efficient separation and purification technology, supercritical extraction technology, microcapsule and targeting technology have been promoted in pharmaceutical production.

At the same time, a large number of herbal medicines and natural medicines produced by the company, such as berberine for anti-infection, colchicine for anti-tumor, and artemisinin for anti-malaria, have begun to be mass-produced and widely used.

The largest sales volume of "Liujiazhuang Pharmaceutical Group" is also prescription drugs.

In addition, "Liujiazhuang Pharmaceutical" is also based on three major business segments: Chinese medicinal materials planting, Chinese herbal medicine processing, and Chinese medicinal materials bulk trade.

In addition, the acquisition of other pharmaceutical companies is conducive to improving its own business layout and resource allocation, ensuring the quality of raw materials for Chinese patent medicines, and developing high-end fine herbal medicines and health products to achieve the expansion of Chinese medicine health business.

Last year, the operating income of "Liujiazhuang Pharmaceutical Group" reached 145.5 billion yuan, and its non-net profit was 14.95 billion yuan.

Traditional Chinese medicines amounted to 95.7 billion yuan, accounting for 66% of the total, and chemical medicines amounted to 60.8 billion yuan, accounting for 34%. The core categories grew steadily.

As the second-generation head of "Liujiazhuang Pharmaceutical Group", Liu Shujia told Wang Shuang, a reporter from Yanjing Daily: "We have the vision of building a century-old enterprise. The pharmaceutical industry in Xiaguo is undergoing profound and long-term changes. How to actively respond to changes in the external environment, while maintaining the steady growth of the original business, maximize the use of our own advantages, and achieve transformation and upgrading in a timely manner is the biggest issue we have faced in recent years."

Not afraid of change, adapting to change, embracing change. In the face of pressure, Liu Shujia said that he will take "traditional Chinese medicine as the basis, innovation-led, and focused on characteristic pharmaceutical and health enterprises" as the strategic development direction, go all out, advance steadily, and persist in creating long-term value for the company.

Afterwards, Liu Shujia took Yanjing Daily reporter Wang Shuang to visit the headquarters exhibition hall of "Liujiazhuang Pharmaceutical Group".

The yellowed old photos in the exhibition hall show the original appearance of "Liujiazhuang Pharmaceutical Factory".

This old pharmaceutical factory located on the north bank of the Yongding River has a particularly eye-catching colorful sign. The spacious white factory area, busy assembly lines, and the original R&D laboratories... show that "Liujiazhuang Pharmaceutical" was full of vitality and potential in the 1960s and 1970s.

Today, this pharmaceutical company, which was established in the late 1960s, has been transformed:
Modern laboratories gather cutting-edge innovative forces, brand-new automated production workshops are under construction in full swing, various pills are moving quickly on the assembly line, and high-quality medicine sources are spread all over the country...

Having shed its youthfulness and entered its forties, Liujiazhuang Pharmaceutical has grown together with the Liujiazhuang High-tech Development Zone.

In the domestic bio-pharmaceutical industry landscape, "Liujiazhuang Pharmaceutical Group" is both a "veteran" and a "newcomer."

While adhering to the advantages of traditional Chinese medicine, we actively explore innovative drugs, chemical generic drugs and other tracks.

Liu Shujia, Chairman of "Liujiazhuang Pharmaceutical Group", said that after forty years of development;
At present, "Liujiazhuang Pharmaceutical Group" has formed a chemical medicine industry chain from raw materials to preparation production, and a traditional Chinese medicine industry chain from medicinal material planting to processing of traditional Chinese medicine pieces and production of traditional Chinese medicines;
As well as the ecological chain of drug production, health services and health management around eye health services.

The layout of the entire industrial chain has enabled the core competitiveness of "Liujiazhuang Pharmaceutical Group" to be continuously strengthened, laying the foundation for further improving quality and efficiency.

There is more good news about the internationalization of traditional Chinese medicine!
Yanjing reporter Wang Shuang recently learned that the Danning tablets developed and produced by the "Liujiazhuang Pharmaceutical Group" many years ago have passed many checkpoints and are expected to be shipped to the Maple Leaf Country by an international logistics company in September this year, and will arrive at the Port of Toronto soon, realizing the vision of "going abroad" for many years.

This not only sets an example for Chinese medicine to go abroad, but also adds new vitality to the promotion of the "internationalization of Chinese medicine".

Looking back on the overseas journey of "Yanjing Good Medicine", the process was not easy, but it brought inspiration to traditional Chinese medicine that has already or is preparing to set sail overseas.

Danning Tablets are the first national-level new Chinese medicine (Category III) in Yanjing area after the implementation of the new drug review method in the 80s. It has been nearly 15 years since the "Liujiazhuang Pharmaceutical Group" started developing it.

Danning tablets are Chinese patent medicine tablets made from rhubarb, knotweed, green peel, Imperata root, tangerine peel, curcuma, hawthorn, etc. It can relieve the clinical symptoms caused by chronic cholecystitis and has the effects of soothing the liver and gallbladder, clearing away heat and relieving bowel movements.

Although it has a good "mass base" in China and is a household name, if Danning Tablets want to "go abroad" and enter the mainstream international pharmaceutical market, the first thing it needs to face and solve is the issue of its legality overseas.

Among these, finding the right registration path is particularly important, which will help advance the project later and increase the chances of achieving ideal results.

Liu Shujia told Wang Shuang, a reporter from Yenching University, that after much analysis and discussion, Liujiazhuang Pharmaceutical Group chose to initiate the international registration journey of Danning Tablets through the path of "traditional drug testing based on domestic evidence". Landing the international registration in the Maple Leaf Country will also pave the way for entering other Y Federation member countries in the future, which can be described as "killing two birds with one stone".

"Liujiazhuang Pharmaceutical Group" has continuously improved its technology and enriched its experience in the course of its development over the years. It adheres to the purpose of "innovating traditional Chinese medicine and serving a healthy China" and maintains a professional attitude to move forward.

As a "milestone" of Liujiazhuang Pharmaceutical Group in exploring the internationalization of traditional Chinese medicine, Danning Tablets provide a reference for more traditional Chinese medicines and pharmaceutical companies that hope to go abroad and go global.

This year, the Xia country formally proposed the strategy of "modernization of traditional Chinese medicine", and the goal of "internationalization of traditional Chinese medicine" has been established for many years.

For traditional Chinese medicine to "go global", "scientific evidence" is the key, and it is equally important to connect with international rules.

After international registration, finished product verification, site certification, contract signing and unified quality, Danning Tablets finally went overseas and successfully achieved its internationalization goal.

Liu Shujia of Liujiazhuang Pharmaceutical Group said: "We have always insisted on applying scientific research to interpret the clinical value of traditional Chinese medicine and strived to achieve the goal of modernization and internationalization of traditional Chinese medicine. Today, we have finally achieved our interim goal."

"Liujiazhuang Pharmaceutical Group" is not only keen on developing new products, but its old drugs on the market are also continuing to occupy the market.

That year, the "Liujiazhuang Pharmaceutical Factory"'s goal of "revitalizing traditional Chinese medicine and going global" was like an inspiring clarion call, inspiring all employees to forge ahead.

Guided by this goal, "Liujiazhuang Pharmaceutical" has continuously increased its investment in research and development, launched a series of market-competitive products, gradually emerged in the national pharmaceutical industry, and became a leader in the industry.

The main drugs of "Liujiazhuang Pharmaceutical Group", such as "Ganmao Qingre Granules", "Children's Cold Granules", "Weitaining", "Isatis Root Granules", "Niuhuang Jiedu Tablets", "Shuanglian Oral Liquid", "Ermiao Pills", "Xiangsha Yangwei Pills", "Liuwei Dihuang Pills", "Ejiao Buxue Oral Liquid", "Tianwang Buxin Pills" and other Chinese patent medicines occupy half of the similar Chinese patent medicines at home and abroad.

"Liujiazhuang Pharmaceutical" actively develops new drugs, which is also inseparable from the collection and protection of ancient folk Chinese medicine prescriptions for decades.

Chairman Liu Shudong said: Ancient folk Chinese medicine prescriptions are valuable experiences summarized by successive generations of Chinese medicine practitioners in practice. They play an important role in treating special diseases or providing special therapeutic effects, and are an important source for the development of new Chinese medicines.

“Regarding the traditional Chinese medicine prescriptions, I suggest that their concept should be clearly defined, and through publicity and education, people should be made aware of their value, importance and significance of inheritance.

In addition, we need to promote cooperation between traditional Chinese medicine and local pharmaceutical companies, and cooperate with the international community to promote the global protection and inheritance of traditional Chinese medicine."

(End of this chapter)